A new role for NF-kappaB in angiogenesis inhibition.

Angiostatic Proteins/physiology/therapeutic use; Animals; Endothelial Cells/physiology; Humans; Models, Biological; NF-kappa B/physiology/therapeutic use; Neoplasms/blood supply/etiology/therapy; Neovascularization, Pathologic/prevention & control; Signal Transduction

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Tabruyn, Sébastien ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire

Griffioen, A. W.

Language :

English

Title :

A new role for NF-kappaB in angiogenesis inhibition.

Publication date :

2007

Journal title :

Cell Death and Differentiation

ISSN :

1350-9047

eISSN :

1476-5403

Publisher :

Nature Publishing Group, London, United Kingdom

Volume :

Issue :

Pages :

1393-7

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 26 November 2010

Statistics

Number of views

52 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Carmeliet P. Nature 2005; 438: 932-936.
Komuro H et al. J Cancer Res Clin Oncol 2001; 127: 739-743.
Abdollahi A et al. Cancer Res 2003; 63: 8890-8898.
Tabruyn SP, Griffioen AW. Biochem Biophys Res Commun 2007; 355 1-5.
Melisi D, Chiao PJ. Expert Opin Ther Targets 2007; 11: 133-144.
Kisseleva T et al. J Clin Invest 2006; 116: 2955-2963.
Mountain DJ et al. Am J Physiol Cell Physiol 2007; 292: C867-C875.
Popov Y et al. J Biol Chem 2006; 281: 15090-15098.
Ko HM et al. FEBS Lett 2005; 579: 6451-6458.
Wilczynska KM et al. J Biol Chem 2006; 281: 34955-34964.
Castellino FJ, Ploplis VA. Thromb Haemost 2005; 93: 647-654.
Swiatkowska M et al. FEBS J 2005; 272: 5821-5831.
Ulfhammer E et al. J Thromb Haemost 2006; 4: 1781-1789.
Iivanainen E et al. Microsc Res Tech 2003; 60: 13-22.
Rice J et al. J Vasc Res 2006; 43: 422-436.
Tong Q et al. Respir Res 2006; 7: 37.
Xiao Q et al. Biochem J 2005; 388 (Part 3): 913-920.
Yang YL et al. Biochem J 2004; 379 (Part 1): 89-97.
Joyce D et al. Cytokine Growth Factor Rev 2001; 12: 73-90.
Feng B et al. Cell Immunol 2004, 232: 9-20.
Basile JR et al. Mol Cancer Res 2003; 1: 262-270.
Nencioni A et al. Leukemia 2007; 21: 30-36.
Radhakrishnan SK, Kamalakaran S. Biochim Biophys Acta 2006; 1766: 53-62.
Dutta J et al. Oncogene 2006; 25: 6800-6816.
van Hogerlinden M et al. Cancer Res 1999; 59: 3299-3303.
Ho FM et al. Circulation 2000; 101: 2618-2624.
Ho FM et al. Cell Signal 2006; 18: 391-399.
Chandrasekar B et al. J Biol Chem 2004; 279: 20221-20233.
Yoo HG et al. Int J Mol Med 2004; 13: 81-86.
Grosjean J et al. Biochem Biophys Res Commun 2006; 340: 984-994.
Festjens N et al. Biochem Biophys Acta 2006; 1757: 1371-1387.
Festjens N et al. Cell Death Differ 2007; 14: 400-410.
Chng HW et al. Exp Cell Res 2006; 312: 2897-2907.
Tabruyn SP et al. Mol Endocrinol 2005; 19: 1932-1942.
Tabruyn SP et al. Mol Endocrinol 2003; 17: 1815-1823.
Bikfalvi A. Semin Thromb Hemost 2004; 30: 379-385.
Yu G et al. Blood 2005; 105: 3545-3551.
Chen YH et al. Thromb Haemost 2006; 95: 668-677.
Hindler K et al. Oncologist 2006; 11: 306-315.
Nakata S et al. Arterioscler Thromb Vasc Biol 2007; 27: 92-98.
Gingras D et al. Biochem Biophys Res Commun 2004; 320: 205-212.
Lucas R et al. Curr Cancer Drug Targets 2005; 5: 381-392.
van Laarhoven HW et al. Invest New Drugs 2006; 24: 27-36.
Hammer DA. Curr Biol 2005; 15: R96-R99.
Griffioen AW et al. Blood 1996; 88: 667-673.
Wu NZ et al. Cancer Res 1992; 52: 4265-4268.
Tromp SC et al. Int Immunol 2000; 12: 671-676.
Flati V et al. Int J Immunopathol Pharmacol 2006; 19: 761-773.
Dirkx AE et al. Faseb J 2006; 20: 621-630.
Luo J et al. Biochem Biophys Res Commun 1998: 245: 906-911.
Thijssen VL et al. Proc Natl Acad Sci USA 2006; 103: 15975-15980.
Masamune A et al. Am J Physiol Gastrointest Liver Physiol 2006; 290: G729-G736.